Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

1,866 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants.
Gilligan AM, Franchino-Elder J, Song X, Wang C, Henriques C, Sainski-Nguyen A, Wilson K, Smith DM, Sander S. Gilligan AM, et al. Among authors: smith dm. Curr Med Res Opin. 2018 Feb;34(2):285-295. doi: 10.1080/03007995.2017.1409425. Epub 2017 Nov 30. Curr Med Res Opin. 2018. PMID: 29166800
Comparison of stroke- and bleed-related healthcare resource utilization and costs among patients with newly diagnosed non-valvular atrial fibrillation and newly treated with dabigatran, rivaroxaban, or warfarin.
Gilligan AM, Franchino-Elder J, Song X, Wang C, Henriques C, Sainski-Nguyen A, Wilson K, Smith DM, Sander S. Gilligan AM, et al. Among authors: smith dm. Expert Rev Pharmacoecon Outcomes Res. 2019 Apr;19(2):203-212. doi: 10.1080/14737167.2019.1527220. Epub 2018 Oct 4. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 30251553
1,866 results